nodes	percent_of_prediction	percent_of_DWPC	metapath
Dactinomycin—germ cell cancer—malignant glioma	0.478	0.52	CtDrD
Dactinomycin—peripheral nervous system neoplasm—malignant glioma	0.441	0.48	CtDrD
Dactinomycin—Radiation injury—Temozolomide—malignant glioma	0.0115	0.151	CcSEcCtD
Dactinomycin—Venoocclusive disease—Carmustine—malignant glioma	0.0109	0.142	CcSEcCtD
Dactinomycin—Myelosuppression—Carmustine—malignant glioma	0.00267	0.0349	CcSEcCtD
Dactinomycin—Myelosuppression—Temozolomide—malignant glioma	0.00258	0.0337	CcSEcCtD
Dactinomycin—Febrile neutropenia—Carmustine—malignant glioma	0.00208	0.0272	CcSEcCtD
Dactinomycin—Febrile neutropenia—Temozolomide—malignant glioma	0.00201	0.0263	CcSEcCtD
Dactinomycin—Hepatotoxicity—Carmustine—malignant glioma	0.00162	0.0212	CcSEcCtD
Dactinomycin—Necrosis—Carmustine—malignant glioma	0.00159	0.0209	CcSEcCtD
Dactinomycin—Hepatotoxicity—Temozolomide—malignant glioma	0.00157	0.0205	CcSEcCtD
Dactinomycin—Coagulopathy—Temozolomide—malignant glioma	0.00155	0.0203	CcSEcCtD
Dactinomycin—Extravasation—Carmustine—malignant glioma	0.00143	0.0188	CcSEcCtD
Dactinomycin—Aplastic anaemia—Temozolomide—malignant glioma	0.00113	0.0149	CcSEcCtD
Dactinomycin—Sepsis—Carmustine—malignant glioma	0.00109	0.0142	CcSEcCtD
Dactinomycin—Phlebitis—Carmustine—malignant glioma	0.00105	0.0138	CcSEcCtD
Dactinomycin—Hepatic failure—Temozolomide—malignant glioma	0.000976	0.0128	CcSEcCtD
Dactinomycin—Liver function test abnormal—Carmustine—malignant glioma	0.000838	0.011	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00079	0.0103	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00079	0.0103	CcSEcCtD
Dactinomycin—Dysphagia—Carmustine—malignant glioma	0.000785	0.0103	CcSEcCtD
Dactinomycin—Dysphagia—Temozolomide—malignant glioma	0.000758	0.00993	CcSEcCtD
Dactinomycin—Pancytopenia—Carmustine—malignant glioma	0.000745	0.00975	CcSEcCtD
Dactinomycin—Neutropenia—Carmustine—malignant glioma	0.000734	0.0096	CcSEcCtD
Dactinomycin—Pancytopenia—Temozolomide—malignant glioma	0.00072	0.00943	CcSEcCtD
Dactinomycin—Neutropenia—Temozolomide—malignant glioma	0.000709	0.00928	CcSEcCtD
Dactinomycin—Pneumonia—Carmustine—malignant glioma	0.000704	0.00921	CcSEcCtD
Dactinomycin—Stomatitis—Carmustine—malignant glioma	0.000682	0.00893	CcSEcCtD
Dactinomycin—Pneumonia—Temozolomide—malignant glioma	0.00068	0.0089	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00067	0.00877	CcSEcCtD
Dactinomycin—Stomatitis—Temozolomide—malignant glioma	0.000659	0.00863	CcSEcCtD
Dactinomycin—Hepatitis—Temozolomide—malignant glioma	0.000607	0.00794	CcSEcCtD
Dactinomycin—Pharyngitis—Temozolomide—malignant glioma	0.000602	0.00788	CcSEcCtD
Dactinomycin—Flushing—Carmustine—malignant glioma	0.000583	0.00763	CcSEcCtD
Dactinomycin—Erythema multiforme—Temozolomide—malignant glioma	0.000574	0.00751	CcSEcCtD
Dactinomycin—Flushing—Temozolomide—malignant glioma	0.000563	0.00737	CcSEcCtD
Dactinomycin—Alopecia—Carmustine—malignant glioma	0.000555	0.00726	CcSEcCtD
Dactinomycin—Erythema—Carmustine—malignant glioma	0.000547	0.00716	CcSEcCtD
Dactinomycin—Chills—Temozolomide—malignant glioma	0.000545	0.00713	CcSEcCtD
Dactinomycin—Alopecia—Temozolomide—malignant glioma	0.000536	0.00702	CcSEcCtD
Dactinomycin—Erythema—Temozolomide—malignant glioma	0.000528	0.00692	CcSEcCtD
Dactinomycin—Anaemia—Carmustine—malignant glioma	0.000505	0.00661	CcSEcCtD
Dactinomycin—Ill-defined disorder—Temozolomide—malignant glioma	0.00049	0.00642	CcSEcCtD
Dactinomycin—Leukopenia—Carmustine—malignant glioma	0.000489	0.00641	CcSEcCtD
Dactinomycin—Anaemia—Temozolomide—malignant glioma	0.000488	0.00639	CcSEcCtD
Dactinomycin—Malaise—Temozolomide—malignant glioma	0.000476	0.00624	CcSEcCtD
Dactinomycin—Leukopenia—Temozolomide—malignant glioma	0.000473	0.00619	CcSEcCtD
Dactinomycin—Myalgia—Carmustine—malignant glioma	0.000465	0.00609	CcSEcCtD
Dactinomycin—Myalgia—Temozolomide—malignant glioma	0.00045	0.00589	CcSEcCtD
Dactinomycin—Oedema—Carmustine—malignant glioma	0.000446	0.00584	CcSEcCtD
Dactinomycin—Discomfort—Temozolomide—malignant glioma	0.000444	0.00582	CcSEcCtD
Dactinomycin—Infection—Carmustine—malignant glioma	0.000443	0.0058	CcSEcCtD
Dactinomycin—Thrombocytopenia—Carmustine—malignant glioma	0.000437	0.00572	CcSEcCtD
Dactinomycin—Oedema—Temozolomide—malignant glioma	0.000431	0.00564	CcSEcCtD
Dactinomycin—Infection—Temozolomide—malignant glioma	0.000428	0.00561	CcSEcCtD
Dactinomycin—Anorexia—Carmustine—malignant glioma	0.000425	0.00557	CcSEcCtD
Dactinomycin—Thrombocytopenia—Temozolomide—malignant glioma	0.000422	0.00553	CcSEcCtD
Dactinomycin—Anorexia—Temozolomide—malignant glioma	0.000411	0.00538	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000407	0.00532	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000393	0.00514	CcSEcCtD
Dactinomycin—Decreased appetite—Carmustine—malignant glioma	0.000388	0.00508	CcSEcCtD
Dactinomycin—Pain—Carmustine—malignant glioma	0.000382	0.00499	CcSEcCtD
Dactinomycin—Decreased appetite—Temozolomide—malignant glioma	0.000375	0.00491	CcSEcCtD
Dactinomycin—Fatigue—Temozolomide—malignant glioma	0.000372	0.00487	CcSEcCtD
Dactinomycin—Pain—Temozolomide—malignant glioma	0.000369	0.00483	CcSEcCtD
Dactinomycin—Feeling abnormal—Carmustine—malignant glioma	0.000368	0.00481	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Carmustine—malignant glioma	0.000365	0.00478	CcSEcCtD
Dactinomycin—Feeling abnormal—Temozolomide—malignant glioma	0.000355	0.00465	CcSEcCtD
Dactinomycin—Body temperature increased—Carmustine—malignant glioma	0.000353	0.00462	CcSEcCtD
Dactinomycin—Abdominal pain—Carmustine—malignant glioma	0.000353	0.00462	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000353	0.00462	CcSEcCtD
Dactinomycin—Abdominal pain—Temozolomide—malignant glioma	0.000341	0.00446	CcSEcCtD
Dactinomycin—Body temperature increased—Temozolomide—malignant glioma	0.000341	0.00446	CcSEcCtD
Dactinomycin—Hypersensitivity—Carmustine—malignant glioma	0.000329	0.0043	CcSEcCtD
Dactinomycin—Asthenia—Carmustine—malignant glioma	0.00032	0.00419	CcSEcCtD
Dactinomycin—Hypersensitivity—Temozolomide—malignant glioma	0.000318	0.00416	CcSEcCtD
Dactinomycin—Asthenia—Temozolomide—malignant glioma	0.000309	0.00405	CcSEcCtD
Dactinomycin—Diarrhoea—Carmustine—malignant glioma	0.000305	0.004	CcSEcCtD
Dactinomycin—Diarrhoea—Temozolomide—malignant glioma	0.000295	0.00386	CcSEcCtD
Dactinomycin—Vomiting—Carmustine—malignant glioma	0.000284	0.00371	CcSEcCtD
Dactinomycin—Rash—Carmustine—malignant glioma	0.000281	0.00368	CcSEcCtD
Dactinomycin—Vomiting—Temozolomide—malignant glioma	0.000274	0.00359	CcSEcCtD
Dactinomycin—Rash—Temozolomide—malignant glioma	0.000272	0.00356	CcSEcCtD
Dactinomycin—Nausea—Carmustine—malignant glioma	0.000265	0.00347	CcSEcCtD
Dactinomycin—Nausea—Temozolomide—malignant glioma	0.000256	0.00335	CcSEcCtD
Dactinomycin—ABCC1—S1P1 pathway—KDR—malignant glioma	8.65e-05	0.0185	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—FTH1—malignant glioma	8.57e-05	0.0183	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—NDRG1—malignant glioma	8.3e-05	0.0177	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-2-alpha transcription factor network—FLT1—malignant glioma	8.28e-05	0.0177	CbGpPWpGaD
Dactinomycin—ABCB1—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	7.53e-05	0.0161	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—ATP1B2—malignant glioma	7.49e-05	0.016	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—APOD—malignant glioma	7.29e-05	0.0156	CbGpPWpGaD
Dactinomycin—ABCC1—Arachidonic acid metabolism—PTGS1—malignant glioma	7.28e-05	0.0155	CbGpPWpGaD
Dactinomycin—ABCG2—Iron uptake and transport—TFRC—malignant glioma	7.23e-05	0.0154	CbGpPWpGaD
Dactinomycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	7.18e-05	0.0153	CbGpPWpGaD
Dactinomycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PIM1—malignant glioma	6.7e-05	0.0143	CbGpPWpGaD
Dactinomycin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—malignant glioma	6.18e-05	0.0132	CbGpPWpGaD
Dactinomycin—ABCC1—S1P1 pathway—PTGS2—malignant glioma	6.05e-05	0.0129	CbGpPWpGaD
Dactinomycin—SLC22A5—SLC-mediated transmembrane transport—APOD—malignant glioma	5.26e-05	0.0112	CbGpPWpGaD
Dactinomycin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	5.18e-05	0.0111	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—TFRC—malignant glioma	5.13e-05	0.0109	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-2-alpha transcription factor network—KDR—malignant glioma	4.78e-05	0.0102	CbGpPWpGaD
Dactinomycin—ABCC1—S1P1 pathway—VEGFA—malignant glioma	4.77e-05	0.0102	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—NDRG1—malignant glioma	4.49e-05	0.00958	CbGpPWpGaD
Dactinomycin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—malignant glioma	4.24e-05	0.00905	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—GDNF—malignant glioma	3.89e-05	0.0083	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—TFRC—malignant glioma	3.73e-05	0.00796	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—IL12A—malignant glioma	3.56e-05	0.00759	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—COX8A—malignant glioma	3.44e-05	0.00734	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.43e-05	0.00731	CbGpPWpGaD
Dactinomycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—malignant glioma	3.34e-05	0.00714	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.26e-05	0.00696	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—FTH1—malignant glioma	3.15e-05	0.00671	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—TERT—malignant glioma	3.07e-05	0.00656	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	2.94e-05	0.00627	CbGpPWpGaD
Dactinomycin—ABCC1—Arachidonic acid metabolism—PTGS2—malignant glioma	2.79e-05	0.00595	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—TFRC—malignant glioma	2.77e-05	0.00592	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—ATP1B2—malignant glioma	2.75e-05	0.00587	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—APOD—malignant glioma	2.67e-05	0.00571	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—malignant glioma	2.63e-05	0.00562	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—HLA-C—malignant glioma	2.63e-05	0.00561	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—COX8A—malignant glioma	2.48e-05	0.0053	CbGpPWpGaD
Dactinomycin—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	2.47e-05	0.00528	CbGpPWpGaD
Dactinomycin—SLC22A5—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	2.35e-05	0.00503	CbGpPWpGaD
Dactinomycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	2.3e-05	0.0049	CbGpPWpGaD
Dactinomycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—malignant glioma	2.29e-05	0.00489	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—FTH1—malignant glioma	2.27e-05	0.00485	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—IL12B—malignant glioma	2.23e-05	0.00477	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—COX8A—malignant glioma	2.19e-05	0.00467	CbGpPWpGaD
Dactinomycin—ABCG2—Fluoropyrimidine Activity—TP53—malignant glioma	2.04e-05	0.00435	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—RTEL1—malignant glioma	2.03e-05	0.00433	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	2.02e-05	0.00432	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—FTH1—malignant glioma	2e-05	0.00427	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	1.99e-05	0.00424	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—APOD—malignant glioma	1.93e-05	0.00412	CbGpPWpGaD
Dactinomycin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	1.81e-05	0.00386	CbGpPWpGaD
Dactinomycin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—malignant glioma	1.79e-05	0.00382	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—RTEL1—malignant glioma	1.78e-05	0.00381	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	1.75e-05	0.00373	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—APOD—malignant glioma	1.7e-05	0.00363	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—TERT—malignant glioma	1.66e-05	0.00355	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	1.59e-05	0.00339	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—PDGFRA—malignant glioma	1.56e-05	0.00334	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—HLA-B—malignant glioma	1.55e-05	0.00331	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	1.55e-05	0.00331	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	1.53e-05	0.00327	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—RAF1—malignant glioma	1.48e-05	0.00315	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	1.45e-05	0.0031	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	1.45e-05	0.00309	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—HLA-A—malignant glioma	1.44e-05	0.00307	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	1.4e-05	0.00299	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—TFRC—malignant glioma	1.37e-05	0.00292	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	1.3e-05	0.00277	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—malignant glioma	1.26e-05	0.00268	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—CD80—malignant glioma	1.21e-05	0.00259	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—SLC6A3—malignant glioma	1.2e-05	0.00255	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	1.19e-05	0.00253	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	1.18e-05	0.00252	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—COX8A—malignant glioma	1.16e-05	0.00248	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—BCAN—malignant glioma	1.11e-05	0.00237	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	1.08e-05	0.00231	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	1.04e-05	0.00222	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—COX8A—malignant glioma	1.02e-05	0.00219	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—DTX1—malignant glioma	1e-05	0.00214	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ASMT—malignant glioma	9.9e-06	0.00211	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—TFRC—malignant glioma	9.89e-06	0.00211	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—AKT1—malignant glioma	9.88e-06	0.00211	CbGpPWpGaD
Dactinomycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	9.78e-06	0.00209	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	9.67e-06	0.00206	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—RTEL1—malignant glioma	9.64e-06	0.00206	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—IFNG—malignant glioma	9.6e-06	0.00205	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	9.45e-06	0.00202	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—BCAN—malignant glioma	9.3e-06	0.00199	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	9.22e-06	0.00197	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	9.19e-06	0.00196	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	9.08e-06	0.00194	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—CXCL8—malignant glioma	8.93e-06	0.00191	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ASMT—malignant glioma	8.71e-06	0.00186	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—TFRC—malignant glioma	8.71e-06	0.00186	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	8.65e-06	0.00185	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	8.57e-06	0.00183	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—IL1B—malignant glioma	8.56e-06	0.00183	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—CASP3—malignant glioma	8.54e-06	0.00182	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—IL2—malignant glioma	8.53e-06	0.00182	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	8.49e-06	0.00181	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	8.37e-06	0.00179	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—BCAN—malignant glioma	8.19e-06	0.00175	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	7.99e-06	0.00171	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—HEY2—malignant glioma	7.88e-06	0.00168	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	7.72e-06	0.00165	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—IDH1—malignant glioma	7.7e-06	0.00164	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	7.61e-06	0.00162	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—IDH2—malignant glioma	7.5e-06	0.0016	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—HEY1—malignant glioma	7.3e-06	0.00156	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—VEGFA—malignant glioma	7.25e-06	0.00155	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—HIST1H3B—malignant glioma	7.09e-06	0.00151	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	7.07e-06	0.00151	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CYP2B6—malignant glioma	7.05e-06	0.00151	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	6.89e-06	0.00147	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—IDH2—malignant glioma	6.6e-06	0.00141	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—JAG2—malignant glioma	6.47e-06	0.00138	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—IDH1—malignant glioma	6.45e-06	0.00138	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—SPHK1—malignant glioma	6.24e-06	0.00133	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—TNF—malignant glioma	6.21e-06	0.00133	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CYP2B6—malignant glioma	6.2e-06	0.00132	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	6.18e-06	0.00132	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CYP2C18—malignant glioma	6.11e-06	0.0013	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	5.98e-06	0.00128	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	5.91e-06	0.00126	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.77e-06	0.00123	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—IDH1—malignant glioma	5.68e-06	0.00121	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—COX8A—malignant glioma	5.54e-06	0.00118	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—SPHK1—malignant glioma	5.49e-06	0.00117	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—H3F3A—malignant glioma	5.48e-06	0.00117	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—RAF1—malignant glioma	5.42e-06	0.00116	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CYP2C18—malignant glioma	5.38e-06	0.00115	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	5.34e-06	0.00114	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.25e-06	0.00112	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—JAG1—malignant glioma	5.17e-06	0.0011	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.07e-06	0.00108	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—FBXW7—malignant glioma	5.06e-06	0.00108	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	5.04e-06	0.00107	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GSTT1—malignant glioma	4.94e-06	0.00106	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	4.78e-06	0.00102	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	4.71e-06	0.00101	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ASMT—malignant glioma	4.71e-06	0.001	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	4.71e-06	0.001	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	4.7e-06	0.001	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	4.65e-06	0.000992	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PTGS1—malignant glioma	4.63e-06	0.000989	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.62e-06	0.000985	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	4.54e-06	0.00097	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—BCAN—malignant glioma	4.43e-06	0.000945	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GSTT1—malignant glioma	4.35e-06	0.000929	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	4.32e-06	0.000922	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—BCHE—malignant glioma	4.31e-06	0.000919	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—SLC5A5—malignant glioma	4.25e-06	0.000908	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	4.22e-06	0.0009	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	4.11e-06	0.000878	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PTGS1—malignant glioma	4.08e-06	0.00087	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.02e-06	0.000859	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.99e-06	0.000851	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CDKN2B—malignant glioma	3.97e-06	0.000846	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	3.96e-06	0.000846	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—RAF1—malignant glioma	3.92e-06	0.000836	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—BCHE—malignant glioma	3.79e-06	0.000809	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—HES1—malignant glioma	3.78e-06	0.000807	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—NCOR1—malignant glioma	3.76e-06	0.000803	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—SLC5A5—malignant glioma	3.74e-06	0.000799	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PDGFRA—malignant glioma	3.6e-06	0.000769	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	3.58e-06	0.000764	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—IDH2—malignant glioma	3.57e-06	0.000762	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.48e-06	0.000742	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	3.45e-06	0.000736	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GSTP1—malignant glioma	3.43e-06	0.000732	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CYP2B6—malignant glioma	3.35e-06	0.000716	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CAT—malignant glioma	3.34e-06	0.000712	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—TERT—malignant glioma	3.31e-06	0.000707	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—HLA-A—malignant glioma	3.31e-06	0.000707	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.29e-06	0.000703	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PDGFB—malignant glioma	3.24e-06	0.000691	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.22e-06	0.000687	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—FGFR1—malignant glioma	3.22e-06	0.000687	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—HIF1A—malignant glioma	3.17e-06	0.000677	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—NCOR1—malignant glioma	3.15e-06	0.000672	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—IDH1—malignant glioma	3.07e-06	0.000655	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.07e-06	0.000655	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CAV1—malignant glioma	3.07e-06	0.000654	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.04e-06	0.000649	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GSTP1—malignant glioma	3.02e-06	0.000644	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—SPHK1—malignant glioma	2.97e-06	0.000634	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CAT—malignant glioma	2.93e-06	0.000626	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CYP2C18—malignant glioma	2.91e-06	0.000621	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—BAD—malignant glioma	2.88e-06	0.000615	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—NOTCH1—malignant glioma	2.86e-06	0.00061	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CD80—malignant glioma	2.8e-06	0.000597	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.79e-06	0.000596	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—APC—malignant glioma	2.79e-06	0.000596	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—NCOR1—malignant glioma	2.77e-06	0.000592	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—EGF—malignant glioma	2.76e-06	0.000589	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PTPN11—malignant glioma	2.74e-06	0.000586	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.7e-06	0.000577	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—BRAF—malignant glioma	2.62e-06	0.00056	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CAV1—malignant glioma	2.57e-06	0.000548	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—AKT2—malignant glioma	2.56e-06	0.000545	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PIK3CD—malignant glioma	2.45e-06	0.000524	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.45e-06	0.000524	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GSTT1—malignant glioma	2.35e-06	0.000502	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—FGF2—malignant glioma	2.35e-06	0.000502	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PIK3CG—malignant glioma	2.34e-06	0.000499	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.28e-06	0.000487	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CAV1—malignant glioma	2.26e-06	0.000482	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PPARG—malignant glioma	2.26e-06	0.000482	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PTGS1—malignant glioma	2.2e-06	0.000471	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—MDM2—malignant glioma	2.2e-06	0.000469	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—RAF1—malignant glioma	2.19e-06	0.000468	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—ERBB2—malignant glioma	2.17e-06	0.000463	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PIK3CB—malignant glioma	2.14e-06	0.000457	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PTGS2—malignant glioma	2.12e-06	0.000453	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PIK3CG—malignant glioma	2.06e-06	0.000439	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PIK3CD—malignant glioma	2.06e-06	0.000439	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—BCHE—malignant glioma	2.05e-06	0.000437	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—SLC5A5—malignant glioma	2.02e-06	0.000432	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PPARG—malignant glioma	1.99e-06	0.000424	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.86e-06	0.000398	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PTEN—malignant glioma	1.85e-06	0.000395	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PIK3CD—malignant glioma	1.81e-06	0.000386	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PIK3CB—malignant glioma	1.79e-06	0.000382	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PTGS2—malignant glioma	1.78e-06	0.000379	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—STAT3—malignant glioma	1.65e-06	0.000353	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GSTP1—malignant glioma	1.63e-06	0.000348	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CAT—malignant glioma	1.59e-06	0.000339	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PIK3CB—malignant glioma	1.58e-06	0.000337	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PTGS2—malignant glioma	1.56e-06	0.000333	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PTEN—malignant glioma	1.55e-06	0.000331	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—MYC—malignant glioma	1.54e-06	0.000328	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—EGFR—malignant glioma	1.5e-06	0.000321	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—NCOR1—malignant glioma	1.5e-06	0.00032	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—KRAS—malignant glioma	1.42e-06	0.000303	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PTEN—malignant glioma	1.36e-06	0.000291	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PIK3CA—malignant glioma	1.3e-06	0.000278	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CAV1—malignant glioma	1.22e-06	0.000261	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PIK3CG—malignant glioma	1.11e-06	0.000237	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PIK3CA—malignant glioma	1.09e-06	0.000233	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PPARG—malignant glioma	1.07e-06	0.000229	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—AKT1—malignant glioma	1.07e-06	0.000227	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PIK3CD—malignant glioma	9.78e-07	0.000209	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PIK3CA—malignant glioma	9.61e-07	0.000205	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—AKT1—malignant glioma	8.92e-07	0.00019	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PIK3CB—malignant glioma	8.53e-07	0.000182	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PTGS2—malignant glioma	8.45e-07	0.00018	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—AKT1—malignant glioma	7.85e-07	0.000168	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PTEN—malignant glioma	7.37e-07	0.000157	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PIK3CA—malignant glioma	5.2e-07	0.000111	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—AKT1—malignant glioma	4.25e-07	9.06e-05	CbGpPWpGaD
